Prothena Corp Public (PRTA) Enterprise Value (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Enterprise Value of -$329.5 million for Q1 2026, up 21.17% year-over-year from -$271.9 million in Q1 2025, and down 7.13% quarter-over-quarter from -$307.5 million in Q4 2025.
Prothena Corp Public (PRTA) Enterprise Value (2012 - 2026) Analysis & Trends
Prothena Corp Public's Enterprise Value history runs 15 years deep, the most recent figure standing at -$329.5 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 21.17% year-over-year to -$329.5 million; the TTM figure through Mar 2026 stood at -$329.5 million (up 21.17% YoY), while the FY2025 annual figure was -$307.5 million, up 34.76% from the prior year.
- Enterprise Value for Q1 2026 stood at -$329.5 million, down from -$307.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$307.5 million in Q4 2025, with the low at -$710.4 million in Q4 2022.
- The 5-year median for Enterprise Value is -$519.3 million (2024), against an average of -$515.1 million.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value plunged 57.69% in 2022, then surged 36.29% in 2025.
- Prothena Corp Public's Enterprise Value stood at -$710.4 million in 2022, then advanced by 12.7% to -$620.2 million in 2023, then rose by 23.99% to -$471.4 million in 2024, then surged by 34.76% to -$307.5 million in 2025, then fell by 7.13% to -$329.5 million in 2026.
- Business Quant data shows PRTA's Enterprise Value at -$329.5 million in Q1 2026, -$307.5 million in Q4 2025, and -$330.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | -288.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -288.20 Mn |
| Mar 31, 2026 | -329.46 Mn |
| Dec 31, 2025 | -307.53 Mn |
| Sep 30, 2025 | -330.84 Mn |
| Jun 30, 2025 | -371.40 Mn |
| Mar 31, 2025 | -417.94 Mn |
| Dec 31, 2024 | -471.39 Mn |
| Sep 30, 2024 | -519.26 Mn |
| Jun 30, 2024 | -564.12 Mn |
| Mar 31, 2024 | -547.86 Mn |
| Dec 31, 2023 | -620.18 Mn |
| Sep 30, 2023 | -672.25 Mn |
| Jun 30, 2023 | -660.46 Mn |
| Mar 31, 2023 | -686.18 Mn |
| Dec 31, 2022 | -710.41 Mn |
| Sep 30, 2022 | -495.63 Mn |
| Jun 30, 2022 | -508.80 Mn |
| Mar 31, 2022 | -542.99 Mn |
| Dec 31, 2021 | -579.09 Mn |
| Sep 30, 2021 | -600.10 Mn |